Spring Mountain Capital invests in enterprise technology and healthcare companies across North America
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Spring Mountain Capital focuses on providing expansion capital to companies capitalizing on breakthrough innovations, paradigm shifts, or fundamental market or behavioral changes. SMC invests in sectors of the U.S. economy undergoing the most change and with the highest growth potential: enterprise software, technology-enabled services, digital health, and healthcare services.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2015 | Oncoceutics | Series A | - |
7/2007 | Perquest | Series B | 0 |
9/2020 | Koneksa Health | Series B | 16M |
4/2012 | OpenSlate | Series A | 2.3M |
6/2015 | Activate Healthcare | Venture Round | - |
2/2020 | Maven Clinic | Series C | 52M |
7/2017 | Maven Clinic | Series A | 10.8M |
6/2018 | Vergent Bioscience | Series A | 11.9M |
4/2011 | NXTM | Private Equity Round | - |
1/2015 | OpenSlate | Series A | 0 |
3/2018 | 180 Health Partners | Series B | 0 |
7/2015 | Ziften Technologies | Series C | 24M |
9/2014 | Activate Healthcare | Private Equity Round | - |
9/2014 | Oncoceutics | Venture Round | - |
5/2018 | ReNetX Bio | Series A | - |
4/2019 | Keen Decision Systems | Series A | 4.6M |
9/2017 | IsoPlexis | Series B | 13.5M |
8/2014 | IsoPlexis | Series A | 1.3M |
2/2017 | Doctor.com | Series A | 5M |
4/2013 | Hµrel | Series A | 9.2M |
3/2022 | Everwash | Series B | 6M |
2/2022 | Eyrus | Series A | 0 |
7/2011 | WhipTail | Series A | - |
1/2020 | IsoPlexis | Series C | 0 |
5/2019 | IsoPlexis | Series C | 0 |
8/2018 | RiskSense | Series B | 12M |
8/2021 | RepairSmith | Series B | 42M |
10/2021 | Aware | Series C | 0 |
12/2020 | Aware | Series B | 0 |
3/2018 | Home Captain | Series A | - |
12/2012 | WhipTail | Series C | 31M |
3/2022 | Genomenon | Series B | 0 |
2/2022 | Koneksa Health | Series C | 0 |
1/2012 | WhipTail | Series B | - |
5/2021 | Thentia | Series B | 10M |
1/2016 | Prevalent | Series B | 8M |
10/2022 | Vergent Bioscience | Series B | 0 |
8/2011 | Cleaire | Venture Round | - |
9/2018 | Maven Clinic | Series B | 27M |
4/2017 | SimpleReach | Series B | 0 |
9/2021 | Lessonbee | Seed Round | 1.5M |
11/2022 | Recess | Series A | 5M |
4/2022 | Thentia | Series B | 10M |
11/2021 | Ankyra | Series B | 45M |
11/2010 | Coolerado | Series B | 0 |
1/2016 | Prevalent Networks | Series B | 8M |
4/2022 | Thentia | Series B | 0 |
3/2022 | Genomenon | Series B | 0 |
3/2022 | Everwash | Series B | 0 |
2/2022 | Eyrus | Series A | 0 |
2/2022 | Koneksa Health | Series C | 0 |
11/2021 | Ankyra | Series B | 0 |
10/2021 | Aware | Series C | 0 |
9/2021 | Lessonbee | Seed Round | 0 |
8/2021 | RepairSmith | Series B | 0 |
5/2021 | Thentia | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|